Fiera Capital (Canada)
LGND icon

Fiera Capital (Canada)’s Ligand Pharmaceuticals LGND Stock Holding History

Fiera Capital (Canada)’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27M Buy
135,312
+4,076
+3% +$806K 0.09% 164
2025
Q4 		$24.8M Buy
+131,236
New +$25.2M 0.08% 170
2019
Q3 		– Sell
-16,926
Closed -$1.21M – 670
2019
Q2 		$1.21M Sell
16,926
-838
-5% -$61.7K ﹤0.01% 436
2019
Q1 		$1.39M Sell
17,764
-7,575
-30% -$574K 0.01% 439
2018
Q4 		$2.15M Buy
+25,339
New +$2.7M 0.01% 383

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Fiera Capital (Canada)'s LGND Position: Q1 2026 in Review

Fiera Capital (Canada) increased its Ligand Pharmaceuticals (LGND) stake by 3.1% in Q1 2026, buying an estimated $806K and bringing the position to 135,312 shares worth $27M. The position accounts for 0.09% of the portfolio, ranked #164.

Fiera Capital (Canada) first reported a position in LGND in Q4 2018 and has held it in 5 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Fiera Capital (Canada) held 135,312 shares of Ligand Pharmaceuticals worth $27M as of Q1 2026.
  • Fiera Capital (Canada) bought 4,076 Ligand Pharmaceuticals shares in Q1 2026, an estimated $806K.
  • Ligand Pharmaceuticals made up 0.09% of Fiera Capital (Canada)'s portfolio in Q1 2026, its #164 holding.
  • Fiera Capital (Canada) first reported a position in Ligand Pharmaceuticals in Q4 2018 and has held it in 5 quarters since.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2026, filed 12 May 2026.